Icl stock hits 52-week high at $7.04

Published 01/07/2025, 14:34
© Natali Kadosh, ICL Group PR

ICL Israel Chemicals Ltd (NYSE:ICL) stock reached a significant milestone, hitting a 52-week high of $7.04. The company, with a market capitalization of $9.1 billion and a P/E ratio of 23.5, has maintained consistent dividend payments for 12 consecutive years according to InvestingPro data. This achievement reflects a notable upward trend, with the stock experiencing a 69.8% increase over the past year. The surge in ICL (TASE:ICL)’s stock price underscores investor confidence and interest in the company’s performance and future prospects. InvestingPro analysis indicates the stock is currently trading near its Fair Value, with 8 additional exclusive insights available to subscribers. This 52-week high marks a period of robust growth for ICL, as it continues to capitalize on favorable market conditions and strategic initiatives. The company maintains a healthy financial position with an overall "GOOD" rating from InvestingPro’s comprehensive analysis, which includes detailed metrics and expert insights available in the Pro Research Report.

In other recent news, ICL Group announced its first quarter earnings, which did not meet analyst expectations. The company reported adjusted earnings per share of $0.09, falling short of the $0.10 consensus estimate. Revenue also came in below projections at $1.77 billion, compared to the anticipated $1.85 billion. Despite this, ICL reaffirmed its full-year 2025 guidance, forecasting EBITDA between $950 million to $1.15 billion, and maintained its outlook for potash sales volumes. In another development, ICL announced a dividend distribution totaling $55 million, with shareholders set to receive $0.04260 per share. The dividend record date is June 4, 2025, with payment scheduled for June 18, 2025. The company also provided details on tax implications for the dividend, noting a 25% withholding tax rate for Israeli and foreign residents. Additionally, ICL is focusing on expanding its specialty products business and optimizing costs to drive growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.